Skip to main content
Top
Published in: Journal of Nuclear Cardiology 2/2018

01-04-2018 | Original Article

Assessment of the fate of myocardial necrosis by serial myocardial perfusion imaging

Authors: Francesco Nudi, MD, Natale Di Belardino, MD, Annamaria Pinto, MD, Enrica Procaccini, MD, Giandomenico Neri, MD, Orazio Schillaci, MD, Fabrizio Tomai, MD, Giacomo Frati, MD, Giuseppe Biondi-Zoccai, MD, MStat

Published in: Journal of Nuclear Cardiology | Issue 2/2018

Login to get access

Abstract

Background

Myocardial necrosis after myocardial infarction (MI) is common; extent and severity are however variable. The pattern is recognized by myocardial perfusion imaging (MPI) as fixed perfusion defects (FPD). The fate of such FPD is not well appraised. This study addressed this important issue in a large number of patients undergoing serial MPI in relation to type of intervening therapy.

Methods

Patients with prior MI or MPI-evidence of myocardial necrosis undergoing serial MPI without intervening acute coronary syndromes were included. The fate of necrosis by MPI on per-patient and per-region analysis was analyzed, factoring also the impact of intervening coronary revascularization (CR).

Results

A total of 3691 patients with 25,837 regions were identified, including 1413 (38.3%) subjects with 3358 (13.0%) regions exhibiting necrosis. Serial MPI after 29±21 months confirmed the persistent presence of myocardial necrosis FPD in the vast majority of patients and regions (86%); the consistency was even higher in the presence of moderate or severe necrosis (99%). Neither type nor site of CR significantly impacted on the presence and extent of myocardial necrosis at multivariable analysis.

Conclusions

The finding of myocardial necrosis by MPI remains highly consistent over time, and is not significantly altered by CR.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lim SP, Mc Ardle BA, Beanlands RS, Hessian RC. Myocardial viability: It is still alive. Semin Nucl Med. 2014;44:358–74.CrossRefPubMed Lim SP, Mc Ardle BA, Beanlands RS, Hessian RC. Myocardial viability: It is still alive. Semin Nucl Med. 2014;44:358–74.CrossRefPubMed
3.
go back to reference Jivraj N, Phinikaridou A, Shah AM, Botnar RM. Molecular imaging of myocardial infarction. Basic Res Cardiol. 2014;109:397.CrossRefPubMed Jivraj N, Phinikaridou A, Shah AM, Botnar RM. Molecular imaging of myocardial infarction. Basic Res Cardiol. 2014;109:397.CrossRefPubMed
4.
go back to reference Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol. 2002;39:1151–8.CrossRefPubMed Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol. 2002;39:1151–8.CrossRefPubMed
5.
go back to reference Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH. Panza JA; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.CrossRefPubMedPubMedCentral Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH. Panza JA; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.CrossRefPubMedPubMedCentral
6.
go back to reference Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G. Rouleau JL; STICHES investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511–20.CrossRefPubMedPubMedCentral Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G. Rouleau JL; STICHES investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511–20.CrossRefPubMedPubMedCentral
7.
go back to reference Buckberg GD, Athanasuleas CL, Wechsler AS, Beyersdorf F, Conte JV, Strobeck JE. The STICH trial unravelled. Eur J Heart Fail. 2010;12:1024–7.CrossRefPubMed Buckberg GD, Athanasuleas CL, Wechsler AS, Beyersdorf F, Conte JV, Strobeck JE. The STICH trial unravelled. Eur J Heart Fail. 2010;12:1024–7.CrossRefPubMed
8.
go back to reference Nudi F, Pinto A, Procaccini E, Neri G, Vetere M, Tomai F, Gaspardone A, Biondi-Zoccai G, Schillaci O. A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy. J Nucl Cardiol. 2014;21:807–18.CrossRefPubMed Nudi F, Pinto A, Procaccini E, Neri G, Vetere M, Tomai F, Gaspardone A, Biondi-Zoccai G, Schillaci O. A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy. J Nucl Cardiol. 2014;21:807–18.CrossRefPubMed
9.
go back to reference Nudi F, Neri G, Schillaci O, Pinto A, Procaccini E, Vetere M, Tomai F, Frati G, Biondi-Zoccai G. Time to and risk of cardiac events after myocardial perfusion scintigraphy. J Cardiol. 2015;66:125–9.CrossRefPubMed Nudi F, Neri G, Schillaci O, Pinto A, Procaccini E, Vetere M, Tomai F, Frati G, Biondi-Zoccai G. Time to and risk of cardiac events after myocardial perfusion scintigraphy. J Cardiol. 2015;66:125–9.CrossRefPubMed
10.
go back to reference Nudi F, Schillaci O, Neri G, Pinto A, Procaccini E, Vetere M, Frati G, Tomai F, Biondi-Zoccai G. Prognostic impact of location and extent of vessel-related ischemia at myocardial perfusion scintigraphy in patients with or at risk for coronary artery disease. J Nucl Cardiol. 2016;23:274–84.CrossRefPubMed Nudi F, Schillaci O, Neri G, Pinto A, Procaccini E, Vetere M, Frati G, Tomai F, Biondi-Zoccai G. Prognostic impact of location and extent of vessel-related ischemia at myocardial perfusion scintigraphy in patients with or at risk for coronary artery disease. J Nucl Cardiol. 2016;23:274–84.CrossRefPubMed
11.
go back to reference Biondi-Zoccai G, Pinto AM, Versaci F, Procaccini E, Neri G, Sesti G, Uccioli L, Vetere M, Peruzzi M, Nudi F. Comparative impact of hypoglycemic agents on severity and extent of myocardial ischemia in patients with type 2 diabetes mellitus undergoing myocardial perfusion scintigraphy. J Cardiovasc Pharmacol. 2016;68:162–70. Biondi-Zoccai G, Pinto AM, Versaci F, Procaccini E, Neri G, Sesti G, Uccioli L, Vetere M, Peruzzi M, Nudi F. Comparative impact of hypoglycemic agents on severity and extent of myocardial ischemia in patients with type 2 diabetes mellitus undergoing myocardial perfusion scintigraphy. J Cardiovasc Pharmacol. 2016;68:162–70.
12.
go back to reference Nudi F, Di Belardino N, Versaci F, Pinto A, Procaccini E, Neri G, Vetere M, Frati G, Peruzzi M, Schillaci O, Gaspardone A, Tomai F, Biondi-Zoccai G. Impact of coronary revascularization versus medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy. J Nucl Cardiol. 2016. doi:10.1007/s12350-016-0504-5. Nudi F, Di Belardino N, Versaci F, Pinto A, Procaccini E, Neri G, Vetere M, Frati G, Peruzzi M, Schillaci O, Gaspardone A, Tomai F, Biondi-Zoccai G. Impact of coronary revascularization versus medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy. J Nucl Cardiol. 2016. doi:10.​1007/​s12350-016-0504-5.
13.
14.
go back to reference Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A. Iwanochko RM; PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.CrossRefPubMed Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A. Iwanochko RM; PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.CrossRefPubMed
15.
go back to reference Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D, D’Ascenzo F, Sangiorgi G, Modena MG. Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials. 2011;32:731–40.CrossRefPubMed Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D, D’Ascenzo F, Sangiorgi G, Modena MG. Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials. 2011;32:731–40.CrossRefPubMed
16.
go back to reference Gibbons RJ, Miller TD. Tc-99m sestamibi infarct size as a surrogate endpoint. J Nucl Cardiol. 2005;12:12–9.CrossRefPubMed Gibbons RJ, Miller TD. Tc-99m sestamibi infarct size as a surrogate endpoint. J Nucl Cardiol. 2005;12:12–9.CrossRefPubMed
17.
go back to reference Ibrahim T, Bülow HP, Hackl T, Hörnke M, Nekolla SG, Breuer M, Schömig A, Schwaiger M. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol. 2007;49:208–16.CrossRefPubMed Ibrahim T, Bülow HP, Hackl T, Hörnke M, Nekolla SG, Breuer M, Schömig A, Schwaiger M. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol. 2007;49:208–16.CrossRefPubMed
Metadata
Title
Assessment of the fate of myocardial necrosis by serial myocardial perfusion imaging
Authors
Francesco Nudi, MD
Natale Di Belardino, MD
Annamaria Pinto, MD
Enrica Procaccini, MD
Giandomenico Neri, MD
Orazio Schillaci, MD
Fabrizio Tomai, MD
Giacomo Frati, MD
Giuseppe Biondi-Zoccai, MD, MStat
Publication date
01-04-2018
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 2/2018
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0751-5

Other articles of this Issue 2/2018

Journal of Nuclear Cardiology 2/2018 Go to the issue